Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type

Clinical trial NCT00861120 · COMPLETED

Trial details

NCT number: NCT00861120
Sponsor: Vejle Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2009-04-01
Primary completion: 2011-08-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.